Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GROWTH-SUPPRESSOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 130 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Waerner, T; Gardellin, P; Pfizenmaier, K; Weith, A; Kraut, N
      Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis

      CELL GROWTH & DIFFERENTIATION
    2. Wilkins, JF; Haig, D
      Genomic imprinting of two antagonistic loci

      PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    3. Zelent, A; Guidez, F; Melnick, A; Waxman, S; Licht, JD
      Translocations of the RAR alpha gene in acute promyelocytic leukemia

      ONCOGENE
    4. Negorev, D; Maul, GG
      Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot

      ONCOGENE
    5. Lallemand-Breitenbach, V; Zhu, J; de The, H
      Promyelocytic leukemia, a unique model to design treatments targeting oncogenes

      M S-MEDECINE SCIENCES
    6. Mizuguchi, M; Takashima, S
      Neuropathology of tuberous sclerosis

      BRAIN & DEVELOPMENT
    7. Kawano, Y; Sasaki, M; Nakahira, K; Yoshimine, T; Shimizu, K; Wada, H; Ikenaka, K
      Structural characterization and chromosomal localization of the MAGE-E1 gene

      GENE
    8. Matsumoto, K; Taniura, H; Uetsuki, T; Yoshikawa, K
      Necdin acts as a transcriptional repressor that interacts with multiple guanosine clusters

      GENE
    9. Stone, B; Schummer, M; Paley, PJ; Crawford, M; Ford, M; Urban, N; Nelson, BH
      MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily

      GENE
    10. Wataya-Kaneda, M; Kaneda, Y; Hino, O; Adachi, H; Hirayama, Y; Seyama, K; Satou, T; Yoshikawa, K
      Cells derived from tuberous sclerosis show a prolonged S phase of the cellcycle and increased apoptosis

      ARCHIVES OF DERMATOLOGICAL RESEARCH
    11. Becker, AJ; Lobach, M; Klein, H; Normann, S; Nothen, MM; von Deimling, A; Mizuguchi, M; Elger, CE; Schramm, J; Wiestler, OD; Blumcke, I
      Mutational analysis of TSC1 and TSC2 genes in gangliogliomas

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    12. Regad, T; Saib, A; Lallemand-Breitenbach, V; Pandolfi, PP; de The, H; Chelbi-Alix, MK
      PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator

      EMBO JOURNAL
    13. Hobbs, WE; Brough, DE; Kovesdi, I; DeLuca, NA
      Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival

      JOURNAL OF VIROLOGY
    14. Djavani, M; Rodas, J; Lukashevich, IS; Horejsh, D; Pandolfi, PP; Borden, KLB; Salvato, MS
      Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus

      JOURNAL OF VIROLOGY
    15. Catania, MG; Mischel, PS; Vinters, HV
      Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    16. Masuda, Y; Sasaki, A; Shibuya, H; Ueno, N; Ikeda, K; Watanabe, K
      Dlxin-1, a novel protein that binds D1x5 and regulates its transcriptionalfunction

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Forslund, KO; Nordqvist, K
      The melanoma antigen genes - Any clues to their functions in normal tissues?

      EXPERIMENTAL CELL RESEARCH
    18. Ababneh, M; Gotz, C; Montenarh, M
      Downregulation of the cdc2/cyclin B protein kinase activity by binding of p53 to p34(cdc2)

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    19. Niida, Y; Stemmer-Rachamimov, AO; Logrip, M; Tapon, D; Perez, R; Kwiatkowski, DJ; Sims, K; MacCollin, M; Louis, DN; Ramesh, V
      Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomassuggests different genetic mechanisms for pathogenesis of TSC lesions

      AMERICAN JOURNAL OF HUMAN GENETICS
    20. Murthy, V; Stemmer-Rachamimov, AO; Haddad, LA; Roy, JE; Cutone, AN; Beauchamp, RL; Smith, N; Louis, DN; Ramesh, V
      Developmental expression of the tuberous sclerosis proteins tuberin and hamartin

      ACTA NEUROPATHOLOGICA
    21. Zhong, S; Salomoni, P; Pandolfi, PP
      The transcriptional role of PML and the nuclear body

      NATURE CELL BIOLOGY
    22. Vannucchi, S; Percario, ZA; Chiantore, MV; Matarrese, P; Chelbi-Alix, MK; Fagioli, M; Pelicci, PG; Malorni, W; Fiorucci, G; Romeo, G; Affabris, E
      Interferon-beta induces S phase slowing via up-regulated expression of PMLin squamous carcinoma cells

      ONCOGENE
    23. Niinobe, M; Koyama, K; Yoshikawa, K
      Cellular and subcellular localization of necdin in fetal and adult mouse brain

      DEVELOPMENTAL NEUROSCIENCE
    24. Nakada, Y; Taniura, H; Uetsuki, T; Yoshikawa, K
      Characterization and chromosomal mapping of a human necdin pseudogene

      GENE
    25. Murthy, V; Haddad, LA; Smith, N; Pinney, D; Tyszkowski, R; Brown, D; Ramesh, V
      Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    26. Ruggero, D; Wang, ZG; Pandolfi, PP
      The puzzling multiple lives of PML and its role in the genesis of cancer

      BIOESSAYS
    27. Yoshikawa, K
      Cell cycle regulators in neural stem cells and postmitotic neurons

      NEUROSCIENCE RESEARCH
    28. Folpe, AL; Goodman, ZD; Ishak, KG; Paulino, AFG; Taboada, EM; Meehan, SA; Weiss, SW
      Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres- A novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    29. Ahn, JH; Hayward, GS
      Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection

      VIROLOGY
    30. Carsillo, T; Astrinidis, A; Henske, EP
      Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    31. Mizuguchi, M; Takashima, S; Yamanouchi, H; Nakazato, Y; Mitani, H; Hino, O
      Novel cerebral lesions in the Eker rat model of tuberous sclerosis: Cortical tuber and anaplastic ganglioglioma

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    32. Zhang, P; Chin, W; Chow, LTC; Chan, ASK; Yim, APC; Leung, SF; Mok, TSK; Chang, KS; Johnson, PJ; Chan, JYH
      Lack of expression for the suppressor PML in human small cell lung carcinoma

      INTERNATIONAL JOURNAL OF CANCER
    33. Hennuy, B; Reiter, E; Cornet, A; Bruyninx, M; Daukandt, M; Houssa, P; N'Guyen, VH; Closset, J; Hennen, G
      A novel messenger ribonucleic acid homologous to human MAGE-D is strongly expressed in rat Sertoli cells and weakly in Leydig cells and is regulated by follitropin, lutropin, and prolactin

      ENDOCRINOLOGY
    34. Kogan, SC; Hong, SH; Shultz, DB; Privalsky, ML; Bishop, JM
      Leukemia initiated by PMLRAR alpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable

      BLOOD
    35. El-Husseini, AED; Kwasnicka, D; Yamada, T; Hirohashi, S; Vincent, SR
      BERP, a novel ring finger protein, binds to alpha-actinin-4

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    36. Mizuguchi, M; Ikeda, K; Takashima, S
      Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis

      ACTA NEUROPATHOLOGICA
    37. Suzuki, M; Watanabe, TK; Fujiwara, T; Nakamura, Y; Takahashi, E; Tanigami, A
      Molecular cloning, expression, and mapping of a novel human cDNA, GRP17, highly homologous to human gadd45 and murine MyD118

      JOURNAL OF HUMAN GENETICS
    38. Gerard, M; Hernandez, L; Wevrick, R; Stewart, CL
      Disruption of the mouse necdin gene results in early post-natal lethality

      NATURE GENETICS
    39. Johnson, MW; Emelin, JK; Park, SH; Vinters, HV
      Co-localization of TSC1 and TSG2 gene products in tubers of patients with tuberous sclerosis

      BRAIN PATHOLOGY
    40. Chelbi-Alix, MK; de The, H
      Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins

      ONCOGENE
    41. Koken, MHM; Daniel, MT; Gianni, M; Zelent, A; Licht, J; Buzyn, A; Minard, P; Degos, L; Varet, B; de The, H
      Retinoic acid, but not arsenic trioxide, degrades the PLZF/RAR alpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient

      ONCOGENE
    42. Kogan, SC; Bishop, JM
      Acute promyelocytic leukemia: from treatment to genetics and back

      ONCOGENE
    43. Plank, TL; Logginidou, H; Klein-Szanto, A; Henske, EP
      The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas

      MODERN PATHOLOGY
    44. Chelbi-Alix, MK; Pelicano, L
      Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells

      LEUKEMIA
    45. Vinters, HV; Park, SH; Johnson, MW; Mischel, PS; Catania, M; Kerfoot, C
      Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes

      DEVELOPMENTAL NEUROSCIENCE
    46. Benninghoff, J; Kartarius, S; Teleb, Z; Selter, H; Unteregger, G; Zwergel, T; Wullich, B; Montenarh, M
      Two different forms of p53 localized differently within cells of urogenital tumours

      CANCER LETTERS
    47. Selter, H; Schmidt, G; Villena-Heinsen, C; Montenarh, M
      Humoral immune response to p21(WAF1/CIP1) tumor patients, non-tumorous patients and healthy blood donors

      CANCER LETTERS
    48. Gotz, C; Scholtes, P; Prowald, A; Schuster, N; Nastainczyk, W; Montenarh, M
      Protein kinase CK2 interacts with a multi-protein binding domain of p53

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    49. Zhu, J; Gianni, M; Kopf, E; Honore, N; Chelbi-Alix, M; Koken, M; Quignon, F; Rochette-Egly, C; de The, H
      Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RAR alpha) and oncogenic RAR alpha fusion proteins

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    50. Lallemand-Breitenbach, V; Guillemin, MC; Janin, A; Daniel, MT; Degos, L; Kogan, SC; Bishop, JM; de The, H
      Retinoic acid and arsenic synergize to eradicate leukemic cells in a mousemodel of acute promyelocytic leukemia

      JOURNAL OF EXPERIMENTAL MEDICINE
    51. Guldner, HH; Szostecki, C; Schroder, P; Matschl, U; Jensen, K; Luders, C; Will, H; Sternsdorf, T
      Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif

      JOURNAL OF CELL SCIENCE
    52. Kao, CY; Tanimoto, A; Arima, N; Sasaguri, Y; Padmanabhan, R
      Transactivation of the human cdc2 promoter by adenovirus E1A - E1A inducesthe expression and assembly of a heteromeric complex consisting of the CCAAT box binding factor, CBF/NF-Y, and a 110-kDa DNA-binding protein

      JOURNAL OF BIOLOGICAL CHEMISTRY
    53. Sternsdorf, T; Jensen, K; Reich, B; Will, H
      The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers

      JOURNAL OF BIOLOGICAL CHEMISTRY
    54. Schuster, N; Prowald, A; Schneider, E; Scheidtmann, KH; Montenarh, M
      Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2

      FEBS LETTERS
    55. Du, CC; Redner, RL; Cooke, MP; Lavau, C
      Overexpression of wild-type retinoic acid receptor alpha (RAR alpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RAR alpha-fusion genes

      BLOOD
    56. YOUNG J; POVEY S
      THE GENETIC-BASIS OF TUBEROUS SCLEROSIS

      Molecular medicine today
    57. QUIGNON F; DEBELS F; KOKEN M; FEUNTEUN J; AMEISEN JC; DETHE H
      PML INDUCES A NOVEL CASPASE-INDEPENDENT DEATH PROCESS

      Nature genetics
    58. GABOLI M; GANDINI D; DELVA L; WANG ZG; PANDOLFI PP
      ACUTE PROMYELOCYTIC LEUKEMIA AS A MODEL FOR CROSS-TALK BETWEEN INTERFERON AND RETINOIC ACID PATHWAYS - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS

      Leukemia & lymphoma
    59. Heuser, M; van der Kuip, H; Falini, B; Peschel, C; Huber, C; Fischer, T
      Induction of the pro-myelocytic leukaemia gene by type I and type II interferons

      MEDIATORS OF INFLAMMATION
    60. GIVOL I; GIVOL D; HUGHES SH
      OVEREXPRESSION OF P21(WAF1 CIP1) ARRESTS THE GROWTH OF CHICKEN-EMBRYOFIBROBLASTS THAT OVEREXPRESS E2F1/

      Oncogene
    61. HABIB AA; GULCHER JR; HOGNASON T; ZHENG LY; STEFANSSON K
      THE OMGP GENE, A 2ND-GROWTH SUPPRESSOR WITHIN THE NF1 GENE

      Oncogene
    62. WAGNER P; FUCHS A; GOTZ C; NASTAINCZYK W; MONTENARH M
      FINE MAPPING AND REGULATION OF THE ASSOCIATION OF P53 WITH P34(CDC2)

      Oncogene
    63. Tanimoto, A; Chen, H; Kao, CY; Moran, E; Sasaguri, Y; Padmanabhan, R
      Transactivation of the human cdc2 promoter by adenovirus E1A in cycling cells is mediated by induction of a 110-kDa CCAAT-box-binding factor

      ONCOGENE
    64. VINTERS HV; KERFOOT C; CATANIA M; EMELIN JK; ROPER SN; DECLUE JE
      TUBEROUS SCLEROSIS-RELATED GENE-EXPRESSION IN NORMAL AND DYSPLASTIC BRAIN

      Epilepsy research
    65. TONG JH; FANT X; DUPREZ E; BENOIT G; UPHOFF CC; DREXLER HG; PLA JC; LOFVENBERG E; LANOTTE M
      EXPRESSION PATTERNS OF THE JEM-1 GENE IN NORMAL AND TUMOR-CELLS - UBIQUITY CONTRASTING WITH A FAINT, BUT RETINOID-INDUCED, MESSENGER-RNA EXPRESSION IN PROMYELOCYTIC NB4 CELLS

      Leukemia
    66. AHN JH; BRIGNOLE EJ; HAYWARD GS
      DISRUPTION OF PML SUBNUCLEAR DOMAINS BY THE ACIDIC IE1 PROTEIN OF HUMAN CYTOMEGALOVIRUS IS MEDIATED THROUGH INTERACTION WITH PML AND MAY MODULATE A RING FINGER-DEPENDENT CRYPTIC TRANSACTIVATOR FUNCTION OF PML

      Molecular and cellular biology
    67. TANIMOTO A; KAO CY; CHANG CC; SASAGURI Y; PADMANABHAN R
      DEREGULATION OF CDC2 GENE-EXPRESSION CORRELATES WITH OVEREXPRESSION OF A 110 KDA CCAAT BOX-BINDING FACTOR IN TRANSFORMED-CELLS

      Carcinogenesis (New York. Print)
    68. GRAND RJA; IBRAHIM AP; TAYLOR AMR; MILNER AE; GREGORY CD; GALLIMORE PH; TURNELL AS
      HUMAN-CELLS ARREST IN S-PHASE IN RESPONSE TO ADENOVIRUS-12-E1A

      Virology
    69. CHELBIALIX MK; QUIGNON F; PELICANO L; KOKEN MHM; DETHE H
      RESISTANCE TO VIRUS-INFECTION CONFERRED BY THE INTERFERON-INDUCED PROMYELOCYTIC LEUKEMIA PROTEIN

      Journal of virology
    70. ALI JBM; SEPP T; WARD S; GREEN AJ; YATES JRW
      MUTATIONS IN THE TSC1 GENE ACCOUNT FOR A MINORITY OF PATIENTS WITH TUBEROUS SCLEROSIS

      Journal of Medical Genetics
    71. MACKIE RM; ANDREW N; LANYON WG; CONNOR JM
      CDKN2A GERMLINE MUTATIONS IN UK PATIENTS WITH FAMILIAL MELANOMA AND MULTIPLE PRIMARY MELANOMAS

      Journal of investigative dermatology
    72. WILKINSON GWG; KELLY C; SINCLAIR JH; RICKARDS C
      DISRUPTION OF PML-ASSOCIATED NUCLEAR-BODIES MEDIATED BY THE HUMAN CYTOMEGALOVIRUS MAJOR IMMEDIATE-EARLY GENE-PRODUCT

      Journal of General Virology
    73. PLANK TL; YEUNG RS; HENSKE EP
      HAMARTIN, THE PRODUCT OF THE TUBEROUS SCLEROSIS-1 (TSC1) GENE, INTERACTS WITH TUBERIN AND APPEARS TO BE LOCALIZED TO CYTOPLASMIC VESICLES

      Cancer research
    74. DELGADO R; BOJORGE BD; ALBORESSAAVEDRA J
      ATYPICAL ANGIOMYOLIPOMA OF THE KIDNEY - A DISTINCT MORPHOLOGIC VARIANT THAT IS EASILY CONFUSED WITH A VARIETY OF MALIGNANT NEOPLASMS

      Cancer
    75. ALSALEEM T; WESSNER LL; SCHEITHAUER BW; PATTERSON K; ROACH ES; DREYER SJ; FUJIKAWA K; BJORNSSON J; BERNSTEIN J; HENSKE EP
      MALIGNANT-TUMORS OF THE KIDNEY, BRAIN, AND SOFT-TISSUES IN CHILDREN AND YOUNG-ADULTS WITH THE TUBEROUS SCLEROSIS COMPLEX

      Cancer
    76. GIANNI M; KOKEN MHM; CHELBIALIX MK; BENOIT G; LANOTTE M; CHEN Z; DETHE H
      COMBINED ARSENIC AND RETINOIC ACID TREATMENT ENHANCES DIFFERENTIATIONAND APOPTOSIS IN ARSENIC-RESISTANT NB4 CELLS

      Blood
    77. YOUNG JM; BURLEY MW; JEREMIAH SJ; JEGANATHAN D; EKONG R; OSBORNE JP; POVEY S
      A MUTATION SCREEN OF THE TSC1 GENE REVEALS 26 PROTEIN TRUNCATING MUTATIONS AND 1 SPLICE-SITE MUTATION IN A PANEL OF 79 TUBEROUS SCLEROSIS PATIENTS

      Annals of Human Genetics
    78. HODGES M; TISSOT C; HOWE K; GRIMWADE D; FREEMONT PS
      STRUCTURE, ORGANIZATION, AND DYNAMICS OF PROMYELOCYTIC LEUKEMIA PROTEIN NUCLEAR-BODIES

      American journal of human genetics
    79. SMOLAREK TA; WESSNER LL; MCCORMACK FX; MYLET JC; MENON AG; HENSKE EP
      EVIDENCE THAT LYMPHANGIOMYOMATOSIS IS CAUSED BY TSC2 MUTATIONS - CHROMOSOME 16P13 LOSS OF HETEROZYGOSITY IN ANGIOMYOLIPOMAS AND LYMPH-NODESFROM WOMEN WITH LYMPHANGIOMYOMATOSIS

      American journal of human genetics
    80. JIANG WQ; RINGERTZ N
      ALTERED DISTRIBUTION OF THE PROMYELOCYTIC LEUKEMIA-ASSOCIATED PROTEINIS ASSOCIATED WITH CELLULAR SENESCENCE

      Cell growth & differentiation
    81. KOENIG MG; STURM D; PROWALD A; ISSINGER OG; MONTENARH M
      INTERACTION OF P53 WITH PROTEIN-KINASE CK2 DURING SV40 INDUCED ENTRANCE OF QUIESCENT CELLS INTO THE CELL-CYCLE

      International journal of oncology
    82. JOBERT S; BRAGADONILSSON E; SAMOLYK D; PEDESPAN JM; MARCHAL C; REICHERT S; MALLET J; PITIOT G
      DELETION OF 11 AMINO-ACIDS IN TUBERIN ASSOCIATED WITH SEVERE TUBEROUSSCLEROSIS PHENOTYPES - EVIDENCE FOR A NEW ESSENTIAL DOMAIN IN THE FIRST 3RD OF THE PROTEIN

      European journal of human genetics
    83. YATES JRW; VANBAKEL I; SEPP T; PAYNE SJ; WEBB DW; NEVIN NC; GREEN AJ
      FEMALE GERMLINE MOSAICISM IN TUBEROUS SCLEROSIS CONFIRMED BY MOLECULAR-GENETIC ANALYSIS

      Human molecular genetics
    84. PELICANO L; LI FS; SCHINDLER C; CHELBIALIX MK
      RETINOIC ACID ENHANCES THE EXPRESSION OF INTERFERON-INDUCED PROTEINS - EVIDENCE FOR MULTIPLE MECHANISMS OF ACTION

      Oncogene
    85. BANGA SS; KIM S; HUBBARD K; DASGUPTA T; JHA KK; PATSALIS P; HAUPTSCHEIN R; GAMBERI B; DALLAFAVERA R; KRAEMER P; OZER HL
      SEN6, A LOCUS FOR SV40-MEDIATED IMMORTALIZATION OF HUMAN-CELLS, MAPS TO 6Q26-27

      Oncogene
    86. DAVID G; TERRIS B; MARCHIO A; LAVAU C; DEJEAN A
      THE ACUTE PROMYELOCYTIC LEUKEMIA PML-RAR-ALPHA PROTEIN INDUCES HEPATIC PRENEOPLASTIC AND NEOPLASTIC LESIONS IN TRANSGENIC MICE

      Oncogene
    87. DETHE H
      ARSENIC TRIOXIDE - AFTER RETINOIC ACID, A NEW ONCOGENE TARGETED TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

      MS. Medecine sciences
    88. QUIGNON F; CHEN Z; DETHE H
      RETINOIC ACID AND ARSENIC - TOWARDS ONCOGENE-TARGETED TREATMENTS OF ACUTE PROMYELOCYTIC LEUKEMIA

      Biochimica et biophysica acta, CR. Reviews on cancer
    89. SZOSTECKI C; GULDNER HH; WILL H
      AUTOANTIBODIES AGAINST NUCLEAR DOTS IN PRIMARY BILIARY-CIRRHOSIS

      Seminars in liver disease
    90. CHEN Z; WANG ZY; CHEN SJ
      ACUTE PROMYELOCYTIC LEUKEMIA - CELLULAR AND MOLECULAR-BASIS OF DIFFERENTIATION AND APOPTOSIS

      Pharmacology & therapeutics
    91. MU ZM; LE XF; VALLIAN S; GLASSMAN AB; CHANG KS
      STABLE OVEREXPRESSION OF PML ALTERS REGULATION OF CELL-CYCLE PROGRESSION IN HELA-CELLS

      Carcinogenesis
    92. ZHU J; KOKEN MHM; QUIGNON F; CHELBIALIX MK; DEGOS L; WANG ZY; CHEN Z; DETHE H
      ARSENIC-INDUCED PML TARGETING ONTO NUCLEAR-BODIES - IMPLICATIONS FOR THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

      Proceedings of the National Academy of Sciences of the United Statesof America
    93. FERRUCCI PF; GRIGNANI F; PEARSON M; FAGIOLI M; NICOLETTI I; PELICCI PG
      CELL-DEATH INDUCTION BY THE ACUTE PROMYELOCYTIC LEUKEMIA-SPECIFIC PMLRAR-ALPHA FUSION PROTEIN/

      Proceedings of the National Academy of Sciences of the United Statesof America
    94. KOKEN MHM; REID A; QUIGNON F; CHELBIALIX MK; DAVIES JM; KABAROWSKI JHS; ZHU J; DONG S; CHEN SJ; CHEN Z; TAN CC; LICHT J; WAXMAN S; DETHE H; ZELENT A
      LEUKEMIA-ASSOCIATED RETINOIC ACID RECEPTOR-ALPHA FUSION PARTNERS, PMLAND PLZF, HETERODIMERIZE AND COLOCALIZE TO NUCLEAR-BODIES

      Proceedings of the National Academy of Sciences of the United Statesof America
    95. HE LZ; TRIBIOLI C; RIVI R; PERUZZI D; PELICCI PG; SOARES V; CATTORETTI G; PANDOLFI PP
      ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/

      Proceedings of the National Academy of Sciences of the United Statesof America
    96. AHN JH; HAYWARD GS
      THE MAJOR IMMEDIATE-EARLY PROTEINS IE1 AND IE2 OF HUMAN CYTOMEGALOVIRUS COLOCALIZE WITH AND DISRUPT PML-ASSCCIATED NUCLEAR-BODIES AT VERY EARLY TIMES IN INFECTED PERMISSIVE CELLS

      Journal of virology
    97. LUKONIS CJ; WELLER SK
      FORMATION OF HERPES-SIMPLEX VIRUS TYPE-1 REPLICATION COMPARTMENTS BY TRANSFECTION - REQUIREMENTS AND LOCALIZATION TO NUCLEAR DOMAIN-10

      Journal of virology
    98. GONGORA C; DAVID G; PINTARD L; TISSOT C; HUA TD; DEJEAN A; MECHTI N
      MOLECULAR-CLONING OF A NEW INTERFERON-INDUCED PML NUCLEAR BODY-ASSOCIATED PROTEIN

      The Journal of biological chemistry
    99. PROWALD A; SCHUSTER N; MONTENARH M
      REGULATION OF THE DNA-BINDING OF P53 BY ITS INTERACTION WITH PROTEIN-KINASE CK2

      FEBS letters
    100. VALLIAN S; GAKEN JA; TRAYNER ID; GINGOLD EB; KOUZARIDES T; CHANG KS; FARZANEH F
      TRANSCRIPTIONAL REPRESSION BY THE PROMYELOCYTIC LEUKEMIA PROTEIN, PML

      Experimental cell research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 11:08:02